Get informed when a big investor buys or sells
+ Follow-55.81
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for 6677.TWO is -55.81. That is below the sector sector average of 22.75. Investors often review this figure alongside Anxo Pharmaceutical , Ltd.'s historical trend and sector peers before judging valuation or financial health.
Against its sector companies, 6677.TWO currently prints -55.81 for P/E ratio, while the sector average sits near 22.75. That is roughly 345.3% below the sector mean. Large gaps often invite a closer look at Anxo Pharmaceutical , Ltd.'s growth, margins, and balance sheet.
A P/E ratio of -55.81 for Anxo Pharmaceutical , Ltd. is not 'good' or 'bad' on its own. Compare it with the peer average (22.75) and with 6677.TWO's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting 6677.TWO's P/E ratio (-55.81), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.